Suzanne Angell

Suzanne Angell has held various roles in the corporate world since 1999. Suzanne began their career as an Analyst at Cooper Hill Partners in 1999. In 2006, they became the Managing Member and Advisor of Alpine ESD / C. Kenneth Imports. In 2008, they took on the roles of CFO and COO at Jungell, Inc. From 2012 to 2021, they were the Director of Therapeutics Research and Director of Research at Casdin Capital, LLC. Currently, they are the Director at Celsius Therapeutics.

Suzanne Angell attended Horace Mann from 1988 to 1994 and graduated with a high school degree. Suzanne then went on to attend Yale University from 1994 to 1999, where they earned a Bachelor's degree in Biology, General and English Literature. Finally, they attended The Johns Hopkins University from 2004 to 2007, where they earned a Master of Arts (M.A.) in English Language and Literature/Letters.